Skip to Main Content

Author Details

Simone Chevalier
McGill University Health Centre, McGill University
1977
117
29
PMIDPaper TitleJournal TitlePublished Year
36343786UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways.Cancer Lett2023
37073437Cell-by-cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression.J Pathol Clin Res2023
37037938A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients.Br J Cancer2023
36373402Preoperative Circulating 11-Oxygenated Androgens Are Associated With Metastasis-free Survival in Localized Prostate Cancer.J Urol2023
36347965Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer.Br J Cancer2023
36172886Liquid biopsy-based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer.Clin Transl Sci2022
35411033Fatty acid oxidation enzyme ο3, ο2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients.Oncogene2022
33801279Pathogenic Roles of S100A8 and S100A9 Proteins in Acute Myeloid and Lymphoid Leukemia: Clinical and Therapeutic Impacts.Molecules2021
33828256Urinary oestrogen steroidome as an indicator of the risk of localised prostate cancer progression.Br J Cancer2021
33689800Mitochondria in human acute myeloid leukemia cell lines have ultrastructural alterations linked to deregulation of their respiratory profiles.Exp Hematol2021
32763409Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification-Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples.J Mol Diagn2020
33457554Comparing Perspectives of Canadian Men Diagnosed With Prostate Cancer and Health Care Professionals About Active Surveillance.J Patient Exp2020
30762265Psychosocial adjustment to a prostate cancer diagnosis in a cohort of radical prostatectomy patients in Quebec, Canada.Psychooncology2019
30140035The combination of PTEN deletion and 16p13.3 gain in prostate cancer provides additional prognostic information in patients treated with radical prostatectomy.Mod Pathol2019
30113732Optimization of the 2014 Gleason grade grouping in a Canadian cohort of patients with localized prostate cancer.BJU Int2019
30136199The relationship between body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for prostate cancer.World J Urol2019
31265453Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network.PLoS Med2019
31433512A three-gene DNA methylation biomarker accurately classifies early stage prostate cancer.Prostate2019
31340802Improving ultrasound-based prostate volume estimation.BMC Urol2019
30733309A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate Cancer.Cancer Epidemiol Biomarkers Prev2019
28993510Genomic Gain of 16p13.3 in Prostate Cancer Predicts Poor Clinical Outcome after Surgical Intervention.Mol Cancer Res2018
29884180Describing perspectives of health care professionals on active surveillance for the management of prostate cancer.BMC Health Serv Res2018
30200929The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation.BMC Urol2018
28724614Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer.Genes Dev2017
28152543Asporin is a stromally expressed marker associated with prostate cancer progression.Br J Cancer2017
29078772Canadian Men's perspectives about active surveillance in prostate cancer: need for guidance and resources.BMC Urol2017
26828716Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality-adjusted life-year analysis.Cancer2016
27327090A Simple Variable Number of Tandem Repeat-Based Genotyping Strategy for the Detection of Handling Errors and Validation of Sample Identity in Biobanks.Biopreserv Biobank2016
25578541Electrochemical red-ox therapy of prostate cancer in nude mice.Bioelectrochemistry2015
26714499The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases.EJNMMI Res2015
24406017The prognostic role of ERG immunopositivity in prostatic acinar adenocarcinoma: a study including 454 cases and review of the literature.Hum Pathol2014
25474006Clinical management and burden of prostate cancer: a Markov Monte Carlo model.PLoS One2014
25152453Biopsy characteristics in men with a preoperative diagnosis of prostatic adenocarcinoma with high Gleason score (8-10) predict pathologic outcome in radical prostatectomy.Hum Pathol2014
23484085Simultaneous quantification of mitochondrial DNA damage and copy number in circulating blood: a sensitive approach to systemic oxidative stress.Biomed Res Int2013
24311952Direct cost for initial management of prostate cancer: a systematic review.Curr Oncol2013
24194978Strategies for biochemical and pathologic quality assurance in a large multi-institutional biorepository; The experience of the PROCURE Quebec Prostate Cancer Biobank.Biopreserv Biobank2013
23906537The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer.Mol Cell Endocrinol2013
23680311Endoscopic vascular targeted photodynamic therapy with the photosensitizer WST11 for benign prostatic hyperplasia in the preclinical dog model.J Urol2013
23799002Combining mTOR inhibition with radiation improves antitumor activity in bladder cancer cells in vitro and in vivo: a novel strategy for treatment.PLoS One2013
23409107A novel mechanism of PPAR gamma induction via EGFR signalling constitutes rational for combination therapy in bladder cancer.PLoS One2013
21882212Refining the orthotopic dog prostate cancer (DPC)-1 model to better bridge the gap between rodents and men.Prostate2012
23401739The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression.Transl Oncol2012
23171135PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity.BMC Cancer2012
22200970Banking of fresh-frozen prostate tissue using the alternate mirror image protocol: methods, validation, and impact on the pathological prognostic parameters in radical prostatectomy.Cell Tissue Bank2012
21264218Identification of distinctive patterns of USP19-mediated growth regulation in normal and malignant cells.PLoS One2011
21843533Mitochondrial DNA damage is sensitive to exogenous H(2)O(2) but independent of cellular ROS production in prostate cancer cells.Mutat Res2011
21600602Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate.J Urol2011
19147545The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.Mol Cancer Res2009
20061787Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancer.Cancer Biol Ther2009
19399787Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivo.Prostate2009
  • 1 - 50 of 117

Recommended Authors

Brian W Simons
Center for Comparative Medicine, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 1
Antonio Hurtado-Coll
University of British Columbia
Career Start Year 2002
Number of shared co-authors 11
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 8
Renea A Taylor
Peter MacCallum Cancer Centre
Career Start Year 1999
Number of shared co-authors 5
Eva Corey
University of Washington School of Medicine
Career Start Year 1996
Number of shared co-authors 6
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 5
Peter S Nelson
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 10
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 5
Guido Jenster
Erasmus University Medical Center
Career Start Year 1990
Number of shared co-authors 11
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 5
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 0
Nora M Navone
MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 4
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 8
Michael R Freeman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1987
Number of shared co-authors 4
Beatrice S Knudsen
University of Utah
Career Start Year 1986
Number of shared co-authors 8
Dean A Troyer
Eastern Virginia Medical School
Career Start Year 1985
Number of shared co-authors 8
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 11
David M Nanus
Sandra and Edward Meyer Cancer Center
Career Start Year 1983
Number of shared co-authors 2
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1981
Number of shared co-authors 6
Gail P Risbridger
Biomedicine Discovery Institute, Monash University
Career Start Year 1981
Number of shared co-authors 8
Steven P Balk
Beth Israel Deaconess Medical Center and Harvard Medical School
Career Start Year 1981
Number of shared co-authors 5
Lawrence D True
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 11
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Career Start Year 1979
Number of shared co-authors 8
Christopher S Foster
The Institute of Cancer Research
Career Start Year 1978
Number of shared co-authors 7
Anne E Cress
University of Arizona Cancer Center, College of Medicine, University of Arizona
Career Start Year 1977
Number of shared co-authors 1
Ralph Buttyan
University of British Columbia
Career Start Year 1976
Number of shared co-authors 19
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0
Robert L Vessella
University of Washington
Career Start Year 1974
Number of shared co-authors 3
Stephen R Plymate
University of Washington
Career Start Year 1973
Number of shared co-authors 5
Christer Busch
Uppsala University
Career Start Year 1970
Number of shared co-authors 0

Collaborators

Armen Aprikian
McGill University Health Centre, McGill University
Co-authored papers 51
Eleonora Scarlata
Research Institute of the McGill University Health Center (RI-MUHC)
Co-authored papers 26
Fadi Brimo
McGill University Health Centre, McGill University
Co-authored papers 21
Fred Saad
University of Montreal Health Center
Co-authored papers 16
Louis Lacombe
CHU de Quebec-Universite Laval
Co-authored papers 13
Karl-Philippe Gu??rard
McGill University and the Research Institute of the McGill University Health Centre
Co-authored papers 7
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Co-authored papers 6
Dominique Trudel
Institut du cancer de Montreal
Co-authored papers 4
Ladan Fazli
University of British Columbia
Co-authored papers 4
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers 4
Martin E Gleave
University of British Columbia
Co-authored papers 4
Amina Zoubeidi
University of British Columbia
Co-authored papers 3
Palak G Patel
Queen's University
Co-authored papers 3
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers 3
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 3
Alain Bergeron
Centre de recherche sur le cancer de l'Universite Laval
Co-authored papers 3
John M S Bartlett
University of Edinburgh
Co-authored papers 3
Tamara Jamaspishvili
Queen's University
Co-authored papers 3
Neil E Fleshner
University of Toronto
Co-authored papers 3
Judith Lacoste
Co-authored papers 2
Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers 2
David M Berman
Queen's University
Co-authored papers 2
Jeremy A Squire
University of Sao Paulo
Co-authored papers 2
Anna Y Lee
Ontario Institute for Cancer Research
Co-authored papers 2
Walead Ebrahimizadeh
Current affiliation: IMV Inc.
Co-authored papers 2
Dan Dion
Ontario Institute for Cancer Research (OICR)
Co-authored papers 1
Nadia Boufaied
Research Institute of the McGill University Health Centre
Co-authored papers 1
Anne-Claude Gingras
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 1
Laura Lee
Ontario Institute for Cancer Research (OICR)
Co-authored papers 1
Karen Mackie/
Co-authored papers 1
Release 1.2